🔎 Trials Near Me

Home › Obesity › Mississippi

Obesity clinical trials in Mississippi

15 studies for Obesity are looking for participants at sites in Mississippi.

Cities in Mississippi

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  • Dynamed Clinical Research, LP d/b/a DM Clinical Research, Gulfport
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT06672549

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Jackson Heart Clinic, Jackson
  • Cardiology Associates of North Mississippi, Tupelo
RecruitingPhase 3
Ages 45 to 99 · All sexes · Updated Sep 22, 2026 · NCT07037433

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Fayette
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07784270

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Olive Branch Family Medical Center, Olive Branch
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07783802

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Gulfport
  • AURORA-2 Clinical Site, Jackson
  • AURORA-2 Clinical Site, Olive Branch
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

  • AURORA-1 Clinical Site, Gulfport
  • AURORA-1 Clinical Site, Jackson
  • AURORA-1 Clinical Site, Olive Branch
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743463

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  • DelRicht Research at Gulfport Memorial, Gulfport
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07351045

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Olive Branch Family Medical Center, Olive Branch
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07351058

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

  • ACCOMPLISH-2 Research Site, Gulfport
  • ACCOMPLISH-2 Research Site, Ridgeland
RecruitingPhase 3Healthy volunteers welcome
Ages 18 to 79 · All sexes · Updated Sep 11, 2026 · NCT07654374

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  • Prime Health and Wellness Sky Clinical Research Network Group, Fayette
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Sep 3, 2026 · NCT07684235

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  • Hawthorne Health, Diamondhead
  • Univ of Mississippi Med Center, Jackson
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

  • ACCOMPLISH-1 Research Site, Gulfport
  • ACCOMPLISH-1 Research Site, Ridgeland
RecruitingPhase 3
Ages 18 to 79 · All sexes · Updated Aug 10, 2026 · NCT07654361

The Epidemiology and Pathophysiology of Kidney Disease in HFpEF With Obesity

  • University of Mississippi Medical Center, Jackson
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Jul 4, 2025 · NCT07052539

Time-restricted Eating Acceptability, Efficacy and Safety in Obesity

  • Department of Nutrition and Hospitality Management, University of Mississippi, Oxford
RecruitingHealthy volunteers welcome
Ages 19 to 65 · All sexes · Updated Dec 6, 2024 · NCT06695988

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.